PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
October 13, 2017Scientific Reports42 citationsOpen Access

MiR-200c regulates tumor growth and chemosensitivity to cisplatin in osteosarcoma by targeting AKT2

YLYang LiuSZShutao ZhuXWXiao Wang

Key Points

Key points are not available for this paper at this time.

Abstract

MicroRNAs (miRNAs) expression aberration has been discovered in almost all human cancers, thus offering a group of potential diagnostic markers, prognostic factors and therapeutic targets in tumorigenesis. Now our data showed that miR-200c, which is downregulated in osteosarcoma tissues, drives chemosensitivity to cisplatin in osteosarcoma. We demonstrated that AKT2 is a direct target of miR-200c, Spearman's rank correlation analysis showed that the expression levels of AKT2 and miR-200c in 35 pairs of osteosarcoma specimens were inversely correlated. Moreover, miR-200c inhibited cell proliferation and cell migration. Taken together, for the first time, our results demonstrate that miR-200c plays a significant role in osteosarcoma tumor growth and chemosensitivity by regulating AKT2, which may provide a novel therapeutic strategy for treatment of osteosarcoma.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Liu et al. (2017) studied this question.

synapsesocial.com/papers/6a08835d280cd4e998e8c578https://doi.org/10.1038/s41598-017-14088-3
Ask AI
Helpful
Bookmark
Share
View Full Paper